Flu A and flu B are two different strains of influenza, explains Thomas Russo, M.D., professor and chief of infectious ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

NEW YORK (AP) — The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

The "personalized cancer vaccines" used by the nine patients in the trial were ... but they aren't engineered to target the ...

Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...